EphA2 overexpression in the cancer cell may directly upregulate myeloid-attracting chemokine expression in the tumor cells, but it may also indirectly affect expression in other stromal cells that can secrete these chemoattractants. This evidence concerns the gene EPHA2 and neoplasm.